Ligand Pharmaceuticals
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 58
- Market Cap
- -
- Introduction
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.
A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma
Phase 2
Completed
- Conditions
- Sarcoma, KaposiHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Ligand Pharmaceuticals
- Target Recruit Count
- 27
- Registration Number
- NCT00002212
- Locations
- 🇺🇸
Desert Univ School of Medicine, Palm Springs, California, United States
🇺🇸Tulane Univ School of Medicine, New Orleans, Louisiana, United States
🇺🇸Milton S Hershey Med Ctr, Hershey, Pennsylvania, United States